Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03522220
Other study ID # SFB936 C7
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2016
Est. completion date December 31, 2019

Study information

Verified date June 2018
Source Universitätsklinikum Hamburg-Eppendorf
Contact Maxi Becker, MSc
Email max.becker@uke.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Current pathophysiological models of schizophrenia focus on disconnectivity of distributed neuronal systems to explain the multitude of psychic symptoms. However, therapeutic strategies targeting this specific pathobiology are lacking. Our recent work provides strong evidence that complex video-game training interventions facilitate fronto-hippocampal structural and functional connectivity within 2 months in healthy subjects. The planned project transfers this knowledge into a training study in schizophrenic patients to counteract disease-related disconnectivity. Underlying mechanisms and behavioral effects are extensively parametrized by resting state functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), spectroscopy and clinical short- and long-term outcome.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 31, 2019
Est. primary completion date July 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- clinically stabilized

- at least one schizophrenic episode in their lives

- International Classification of Diseases 10 (ICD-10) F20.x (and F25)

Exclusion Criteria:

- clinically relevant anemia

- MRI contraindication

- earlier electroconvulsive shock treatment

- significant somatic or neurological disease

- significant alcohol or substance abuse in the year before

- more than 1h video games per day more than 6 months before study start

- simultaneous major psychiatric disease (if symptomatic in the foreground)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
3D navigation video game intervention
Participants intensively train with a video game (Super Mario DS)
video game intervention without 3D navigation
Participants train with a video game (Super Mario Bros)
No 3D navigation
Participants read on a kindle device (control group)

Locations

Country Name City State
Germany University Clinic Hamburg-Eppendorf Hamburg

Sponsors (1)

Lead Sponsor Collaborator
Universitätsklinikum Hamburg-Eppendorf

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary T1 - MRI The investigators look for structural volume changes in T1 images (MRI) specifically in the hippocampus and prefrontal areas due to training 2 months (= training time and 2 months after training end)
Primary Cognition - Spatial Orientation The investigators look for changes in cognition specifically regarding spatial orientation (MATRICS, computer tests measuring spatial orientation with and without external cue) due to training. 2 months (= training time and 2 months after training end)
Primary Positive & Negative Symptoms in patients The investigators look for changes in positive and negative symptoms (PANSS) due to training. 2 months (= training time and 2 months after training end)
Secondary Resting State fMRI The investigators look for blood oxygen level dependency (BOLD) changes in resting state fMRI specifically in the Hippocampus and Prefrontal Areas due to the training 2 months (= training time and 2 months after training end)
Secondary Spectroscopy - glutamate The investigators look for glutamate concentration changes in the hippocampus due to the training 2 month (= training time and 2 month after training end)
Secondary Diffusion Tensor Imaging (DTI) The investigators look for structural connectivity changes in DTI images due to the training 2 month (= training time and 2 month after training end)
Secondary Biomarkers (BDNF & interleukin 1 & 6) The investigators look for plasticity induced changes in biomarkers (interleukin1 and 6 and BDNF [brain-derived neurotrophic factor]) due to training 2 month (= training time and 2 month after training end)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1

External Links